Tourniquet vs. no Tourniquet During Total Knee Arthroplasty
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to correlate functional outcomes and perioperative complications with tourniquet use during total knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 15, 2016
CompletedFirst Posted
Study publicly available on registry
September 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedJuly 1, 2019
June 1, 2019
10 months
September 15, 2016
June 27, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
timed up and go (TUG) score
4 weeks following surgery
Stair Climb test
time, in seconds, to climb one flight of nine stairs
in hospital (usually less than 2 days), 4 weeks post-op, 6 months post-op
Visual Analog Scale: Pain
in hospital (usually less than 2 days), 4 weeks post-op, 6 months post-op
Secondary Outcomes (3)
blood loss
intra-operative
surgical field visualization
intra-operative
range of motion
in hospital (usually less than 2 days), 4 weeks post-op, 6 months post-op
Study Arms (2)
Tourniquet
ACTIVE COMPARATORThese subjects will have their tourniquet inflated during key portions of the total knee arthroplasty procedure
No tourniquet
OTHERThese subjects will not have their tourniquet inflated during key portions of the total knee arthroplasty procedure
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of osteoarthritis
You may not qualify if:
- Revision surgery
- Bilateral knee surgery
- Age \<18 or \>80
- BMI \>40
- Baseline lower extremity strength less than 5/5
- Vascular calcifications
- History of chronic narcotic use, defined as more than 5mg of oxycodone q4 hours
- Functionally limiting spine disease
- Other functionally limiting lower extremity disorder (i.e. symptomatic ipsilateral hip disease)
- Patients who cannot perform the baseline functional tests
- Allergy/contraindication to protocol medications
- Post-traumatic arthritis
- Inflammatory arthritis
- Pregnancy
- Prisoners
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rothman Institute
Philadelphia, Pennsylvania, 19148, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2016
First Posted
September 20, 2016
Study Start
June 1, 2016
Primary Completion
April 1, 2017
Study Completion
October 1, 2017
Last Updated
July 1, 2019
Record last verified: 2019-06